Gary Gilkeson to Transforming Growth Factor beta
This is a "connection" page, showing publications Gary Gilkeson has written about Transforming Growth Factor beta.
Connection Strength
0.382
-
Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE. Lupus Sci Med. 2022 07; 9(1).
Score: 0.170
-
B lymphocytes confer immune tolerance via cell surface GARP-TGF-? complex. JCI Insight. 2018 04 05; 3(7).
Score: 0.127
-
Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated Individuals. Front Immunol. 2022; 13:866181.
Score: 0.042
-
Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation. Cell Transplant. 2013; 22(12):2279-90.
Score: 0.022
-
Gene expression profile reveals abnormalities of multiple signaling pathways in mesenchymal stem cell derived from patients with systemic lupus erythematosus. Clin Dev Immunol. 2012; 2012:826182.
Score: 0.021